Rebalancing agents in hemophilia: knowns, unknowns, and uncertainties
Treatment options for patients with hemophilia and other bleeding disorders have advanced dramatically over the last few years, not only with the availability of safer factor concentrates, but also with the introduction of factor VIII-mimicking agents. Until recently, there were still areas of hemo...
Saved in:
| Main Authors: | Quentin Van Thillo, Cédric Hermans |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-07-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12200 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extravascular factor IX after gene therapy in hemophilia B, does it matter?
by: Quentin Van Thillo, et al.
Published: (2025-02-01) -
PO47 | Hemophilia A and antithrombin deficiency: a case of natural hemostatic rebalancing
Published: (2025-08-01) -
Are artificial agents perceived similarly to humans? Knowns, unknowns and the road ahead
by: Marius Rubo, et al.
Published: (2025-08-01) -
Burning mouth syndrome – known and unknown
by: Zlatina Tomova, et al.
Published: (2024-12-01) -
Knowns and unknowns about the neurobiology of stuttering.
by: Nicole E Neef, et al.
Published: (2024-02-01)